Skip to main content
Clinical Trials/NCT05416112
NCT05416112
Recruiting
Not Applicable

Non Invasive Left Ventricle Contractility dp/dt Could be Used as a Prognostic Marker in Patients Admitted to the Emergency Department for Chest Pain

University of Monastir1 site in 1 country500 target enrollmentJune 1, 2022
ConditionsChest Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chest Pain
Sponsor
University of Monastir
Enrollment
500
Locations
1
Primary Endpoint
MACE
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Ischemic heart disease is a major public health problem with high mortality rate despite the progress in management and the resources mobilized. The idea is that myocardial ischemia is generally associated with left ventricular dysfunction and, consequently, a possible alteration of the dp/dt index. As dp/dt could be assessed non-invasively by plethysmographic method, it is interesting to investigate its prognostic performance in patients with indifferentiate chest pain.

Detailed Description

Ischemic heart disease remains a major public health problem. Despite all the advances in the prognostic approach to ischemic heart disease, the risk of occurrence of major cardiovascular events is not negligible. Several scores have been proposed for chest pain stratification risk, the most widely used are the TIMI and the GRACE scores. The dP/dt max is therefore an excellent index of contractility, corresponding to the maximum level of tension developed by an isolated cardiac muscle during the isovolumic contraction phase. the investigator theorized that a less value of dp/dt would be associated with more major cardiovascular events (MACE), because ischemia reduces myocardial contractility. The current study describes non-invasive plethysmographic dp/dt changes, which could be used as a prognostic marker in patients presenting at the emergency department with acute chest pain.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
September 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pr. Semir Nouira

PROFESSOR

University of Monastir

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

MACE

Time Frame: SIX MONTHS

: the occurrence of a major cardiovascular event (MACE)

Study Sites (1)

Loading locations...

Similar Trials